Report Overview
Summary
Leukocare AG (Leukocare) is a clinical stage biotechnology company that offers technologies for stabilizing proteins to increase shelf-life and to facilitate terminal sterilization by irradiation or gas. The company offers services such as development of individual SPS formulations meeting individual needs of target proteins; development of spray drying and spray freeze drying processes; and development of customized lyophilization protocols. It offers development of vaccine formulation; coupling of biological compounds to functionalize surfaces; and establishment of biological read outs. Leukocare provides its services in the areas of physiology, biochemistry, biophysics, pharmaceutical technology, pharmacology, immunology, chemistry and medical engineering. Leukocare is headquartered in Munich, Germany.
Leukocare AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table Of Contents
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Leukocare AG, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Leukocare AG, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Leukocare AG, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Leukocare AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Leukocare AG, Medical Devices Deals, 2011 to YTD 2017 9
Leukocare AG, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Leukocare AG, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Trillium Diagnostics Enters Into Licensing Agreement With Leukocare For Sepsis Dx 11
Rentschler Biotech Enters into Agreement with Leukocare 12
Leukocare Enters into Agreement with Technical University of Munich 13
Licensing Agreements 14
PaxVax Enters into Licensing Agreement with Leukocare 14
LEUKOCARE Enters into Licensing Agreement with Animal Health Provider for Veterinarian Vaccine 15
Leukocare AG - Key Competitors 16
Leukocare AG - Key Employees 17
Leukocare AG - Locations And Subsidiaries 18
Head Office 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19
List of Tables
Leukocare AG, Pharmaceuticals & Healthcare, Key Facts 2
Leukocare AG, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Leukocare AG, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Leukocare AG, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Leukocare AG, Deals By Therapy Area, 2011 to YTD 2017 8
Leukocare AG, Medical Devices Deals, 2011 to YTD 2017 9
Leukocare AG, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Trillium Diagnostics Enters Into Licensing Agreement With Leukocare For Sepsis Dx 11
Rentschler Biotech Enters into Agreement with Leukocare 12
Leukocare Enters into Agreement with Technical University of Munich 13
PaxVax Enters into Licensing Agreement with Leukocare 14
LEUKOCARE Enters into Licensing Agreement with Animal Health Provider for Veterinarian Vaccine 15
Leukocare AG, Key Competitors 16
Leukocare AG, Key Employees 17
List of Figures
Leukocare AG, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 2
Leukocare AG, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 2
Leukocare AG, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 2
Leukocare AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 2
Leukocare AG, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Leukocare AG, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
Leukocare AG, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Leukocare AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Leukocare AG, Medical Devices Deals, 2011 to YTD 2017 9